CytoDyn Inc.
CYDY
$0.204
$0.0031.49%
OTC PK
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 16.40M | 21.34M | 24.92M | 3.11M | 1.40M |
| Total Receivables | 2.00M | 2.00M | 2.00M | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 513.00K | 635.00K | 570.00K | 463.00K | 1.35M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.07M | 663.00K | 247.00K | 7.24M | 7.16M |
| Total Current Assets | 20.98M | 24.63M | 27.74M | 10.82M | 9.91M |
|
|
|||||
| Total Current Assets | 20.98M | 24.63M | 27.74M | 10.82M | 9.91M |
| Net Property, Plant & Equipment | 163.00K | 196.00K | 230.00K | 264.00K | 298.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 44.00K | 48.00K | 53.00K | 57.00K | 62.00K |
| Total Assets | 21.19M | 24.88M | 28.02M | 11.14M | 10.27M |
|
|
|||||
| Total Accounts Payable | 15.13M | 14.24M | 14.16M | 29.56M | 62.08M |
| Total Accrued Expenses | 20.26M | 20.18M | 19.17M | 17.60M | 24.20M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 27.28M | 28.67M | 29.06M | 29.94M | 30.31M |
| Total Finance Division Other Current Liabilities | 7.90M | 7.53M | 7.16M | 7.09M | 12.89M |
| Total Other Current Liabilities | 7.90M | 7.53M | 7.16M | 7.09M | 12.89M |
| Total Current Liabilities | 70.57M | 70.63M | 69.56M | 84.18M | 129.48M |
|
|
|||||
| Total Current Liabilities | 70.57M | 70.63M | 69.56M | 84.18M | 129.48M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 34.00K | 69.00K | 105.00K | 141.00K | 176.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 43.57M | 43.57M | 43.57M | 43.57M | -- |
| Total Liabilities | 114.17M | 114.27M | 113.23M | 127.89M | 129.65M |
|
|
|||||
| Common Stock & APIC | 788.85M | 787.68M | 787.09M | 774.77M | 755.36M |
| Retained Earnings | -881.83M | -877.07M | -872.30M | -891.53M | -874.74M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -92.98M | -89.39M | -85.21M | -116.76M | -119.38M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -92.98M | -89.39M | -85.21M | -116.76M | -119.38M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -92.98M | -89.39M | -85.21M | -116.76M | -119.38M |
|
|
|||||